Literature DB >> 15289020

Pathogenesis of jumping translocations: a molecular cytogenetics study.

T S K Wan1, S K Ma, E Y D Chow, Y H Li, S Y Lin, L C Chan.   

Abstract

BACKGROUND/AIMS: Jumping translocations are rare cytogenetic aberrations in haematological malignancies, the pathogenesis of which remains to be fully characterised. We investigated the mechanism of formation of jumping translocations in a case of adult common acute lymphoblastic leukaemia (ALL) positive for the Ph translocation.
METHODS: Interphase and metaphase fluorescence in situ hybridisation (FISH) was performed using several probe systems. Results were correlated with findings on conventional cytogenetics. Granulocytes, T-cells and leukaemic B-cells in peripheral blood were sorted by immunomagnetic method and the terminal restriction fragment (TRF) length of these cellular populations was determined by Southern blot analysis.
RESULTS: Duplicated BCR-ABL fusion signals were found on a dic(14;22)der(22)t(9;22) chromosome. Clonal jumping translocations, existing as evolutionary changes, involved the donor chromosomal segment distal to 1q12 jumping onto the telomere ends of 11q, 15p, 19p and 20p. Telomere length was decreased in the neoplastic B-cell population and contributed to the formation of the dicentric chromosome that showed absence of telomere repeats at fusion ends. Subsequent pericentromeric heterochromatin decondensation of chromosome 1q occurred, and this donor segment was randomly fused to the shortened telomere ends of non-homologous chromosomes.
CONCLUSIONS: Both telomere shortening and pericentromeric heterochromatin decondensation contribute to the formation of jumping translocations, which is most probably a multi-stage process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15289020     DOI: 10.1016/j.leukres.2004.01.021

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.

Authors:  David Sanford; Courtney D DiNardo; Guilin Tang; Jorge E Cortes; Srdan Verstovsek; Elias Jabbour; Farhad Ravandi; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-06

2.  Jumping translocation in acute monocytic leukemia (M5b) with alternative breakpoint sites in the long arm of donor chromosome 3.

Authors:  Peter McGrattan; Amy Logan; Mervyn Humphreys; Margaret Bowers
Journal:  Med Oncol       Date:  2009-07-22       Impact factor: 3.064

3.  Unbalanced jumping translocation involving 3q in myeloproliferative disease.

Authors:  Peter McGrattan; Mervyn Humphreys; Donald Hull
Journal:  Med Oncol       Date:  2008-05-29       Impact factor: 3.064

4.  Jumping Translocation in a Patient with Acute Leukemia and Fatal Evolution.

Authors:  Irene Sánchez Prieto; Montserrat López Rubio; Eva Arranz; Rosa Ayala; Marta Callejas Charavía; Yolanda Martín Guerrero; Juan José Gil Fernández; Susana Valenciano Martínez; Lucía Castilla García; María Argüello Marina; José María Aspa Cilleruelo; Celia Martínez Vázquez; Julio García Suárez
Journal:  Case Rep Oncol       Date:  2020-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.